Palo Alto, CA, United States of America

Leslie Johnston-Dow

This inventor holds 1 USPTO granted patent. Top assignee: The Perkin-Elmer Corporation. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leslie Johnston-Dow: Innovator in HLA Class I Gene Typing

Introduction

Leslie Johnston-Dow is a prominent inventor based in Palo Alto, CA (US). She has made significant contributions to the field of genetics, particularly in the typing of HLA class I genes. Her innovative methods have the potential to enhance the understanding of genetic variations and their implications in health and disease.

Latest Patents

Leslie Johnston-Dow holds a patent for "Methods and reagents for typing HLA class I genes." This method involves contacting a sample DNA with first and second amplification primers, which are located in an exonic region. The process includes amplifying a target sequence using PCR to form an amplicon, which is then detected with sequence-specific detection means, such as DNA sequencing. The invention also encompasses specific amplification primers, sequencing primers, and kits designed for use with the HLA typing method. She has 1 patent to her name.

Career Highlights

Leslie Johnston-Dow is associated with the Perkin-Elmer Corporation, where she has been able to apply her expertise in genetics and molecular biology. Her work has contributed to advancements in genetic testing and diagnostics.

Collaborations

Throughout her career, Leslie has collaborated with notable colleagues, including Robert B. Chadwick and Peter R. Parham. These collaborations have further enriched her research and innovation in the field.

Conclusion

Leslie Johnston-Dow is a trailblazer in the field of genetic research, particularly in HLA class I gene typing. Her innovative methods and dedication to advancing genetic understanding have made a lasting impact in the scientific community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…